These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9687402)

  • 81. Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.
    Ferrándiz MJ; Oteo J; Aracil B; Gómez-Garcés JL; De La Campa AG
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2520-3. PubMed ID: 10508036
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Primary targets of fluoroquinolones in Streptococcus pneumoniae.
    Fukuda H; Hiramatsu K
    Antimicrob Agents Chemother; 1999 Feb; 43(2):410-2. PubMed ID: 9925547
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Emergence of quinolone-resistant strains in Streptococcus pneumoniae isolated from paediatric patients since the approval of oral fluoroquinolones in Japan.
    Takeuchi N; Ohkusu M; Hoshino T; Naito S; Takaya A; Yamamoto T; Ishiwada N
    J Infect Chemother; 2017 Apr; 23(4):218-223. PubMed ID: 28159338
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B Streptococcus from South Korea.
    Dang TN; Srinivasan U; Britt Z; Marrs CF; Zhang L; Ki M; Foxman B
    Epidemiol Health; 2014; 36():e2014022. PubMed ID: 25322878
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Active efflux of norfloxacin by Bacteroides fragilis.
    Miyamae S; Nikaido H; Tanaka Y; Yoshimura F
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2119-21. PubMed ID: 9687419
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae.
    Gill MJ; Brenwald NP; Wise R
    Antimicrob Agents Chemother; 1999 Jan; 43(1):187-9. PubMed ID: 9869592
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB.
    Garvey MI; Piddock LJ
    Antimicrob Agents Chemother; 2008 May; 52(5):1677-85. PubMed ID: 18362193
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States.
    Sahm DF; Peterson DE; Critchley IA; Thornsberry C
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2521-4. PubMed ID: 10952606
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains.
    Martínez-Martínez L; García I; Ballesta S; Benedí VJ; Hernández-Allés S; Pascual A
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1850-2. PubMed ID: 9661034
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci.
    Guerin F; Varon E; Hoï AB; Gutmann L; Podglajen I
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2197-200. PubMed ID: 10898702
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Fluoroquinolone efflux in Streptococcus suis is mediated by SatAB and not by SmrA.
    Escudero JA; San Millan A; Gutierrez B; Hidalgo L; La Ragione RM; AbuOun M; Galimand M; Ferrándiz MJ; Domínguez L; de la Campa AG; Gonzalez-Zorn B
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5850-60. PubMed ID: 21930876
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi.
    Rampacci E; Marenzoni ML; Cannalire R; Pietrella D; Sabatini S; Giovagnoli S; Felicetti T; Pepe M; Passamonti F
    J Antimicrob Chemother; 2021 Jul; 76(8):2040-2048. PubMed ID: 33855442
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Two classes of ethidium-bromide-resistant mutants of Streptomyces lividans 66.
    Lee LF; Huang YJ; Chen CW
    Microbiology (Reading); 1996 Apr; 142 ( Pt 4)():1041-1047. PubMed ID: 8936330
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens Strains.
    Park M; Rafii F
    Int J Microbiol; 2014; 2014():456979. PubMed ID: 25587280
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of PatAB Transporter in Efflux of Levofloxacin in
    Amblar M; Zaballos Á; de la Campa AG
    Antibiotics (Basel); 2022 Dec; 11(12):. PubMed ID: 36551495
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Development of an Antibiotic Resistance Breaker to Resensitize Drug-Resistant
    Thamilselvan G; Sarveswari HB; Vasudevan S; Stanley A; Shanmugam K; Vairaprakash P; Solomon AP
    Front Cell Infect Microbiol; 2021; 11():700198. PubMed ID: 34485178
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to
    Alvarado M; Martín-Galiano AJ; Ferrándiz MJ; Zaballos Á; de la Campa AG
    Front Microbiol; 2017; 8():2074. PubMed ID: 29123510
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Boeravinone B, A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of
    Singh S; Kalia NP; Joshi P; Kumar A; Sharma PR; Kumar A; Bharate SB; Khan IA
    Front Microbiol; 2017; 8():1868. PubMed ID: 29046665
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.